Tag:
obesity
Latest Headlines
Latest Headlines
Arena pulls app for weight-loss drug Belviq in EU
Arena Pharmaceuticals has decided to take its drug application and go home. The drugmaker Friday said it was giving up for now on breaking through the European wall of resistance to its weight-loss drug Belviq. The company, which got FDA approval last year, yanked its application with little explanation.
UPDATED: Arena shares sink after biotech withdraws marketing app for obesity drug in Europe
Arena Pharmaceuticals pulled the plug on its application for approval of the obesity drug Belviq with European regulators, another blow to the commercial and regulatory effort behind the treatment. The San Diego-based biotech revealed the decision to withdraw the app in its first-quarter financial report late Thursday afternoon.
Allergan mulls suitors for obesity intervention unit
Allergan says it is mulling potential buyers for its obesity intervention unit and is on track to sell the division by mid-2013.
BAROnova's anti-obesity device aces early trial
Fresh off closing $27.3 million in venture funding, California's BAROnova is touting positive trial results of its non-surgical anti-obesity device, the TransPyloric Shuttle.
U.K. team wins $9.1M to develop electronic anti-obesity implant
Researchers at Imperial College London in the U.K. are hard at work developing a new anti-obesity electronic implant, backed by a $9.1 million grant from a pan-European government agency.
Canker sore drug reverses weight gain in mice
When screening nearly 150,000 drugs for metabolic properties in an attempt to find an anti-obesity therapy, scientists stumbled upon an unlikely candidate--a drug used to treat canker sores.
Vivus hopes weight-loss app will fatten up Qsymia sales
Weight-loss apps have become popular, so why not a weight-loss app for a weight-loss drug? Qsymia maker Vivus figures it is worth a try.
Vivus dials up iPhone app to boost Qsymia sales
Weight-loss apps have become popular, so why not a weight-loss app for a weight-loss drug? Qsymia maker Vivus figures it is worth a try.
Deleting a gene in mice prevents obesity
Scientists may have found a way to prevent obesity, effectively curbing weight gain in mice that were given a high-fat diet.
Vivus investor plots board takeover to rally Qsymia sales
Vivus may rue the day that it decided to go solo on marketing its new obesity drug, Qsymia. Despite some fanfare around its U.S. approval, the drug's sales have foundered. Vivus is trying to move Qsymia off the rocks, but so far, the market is unconvinced.
